Turner Christopher Durant
Chief Medical Officer at NUVL
- Sold, on record
- $2.2M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Jan 6, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NUVLNuvalent, Inc.Chief Medical Officer
Sales by reason
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale NUVLRoutineJul 24, 2023 2023
Sold 300 shares at $46.81 ($14k)
Turner Christopher Durant, Chief Medical Officer
10b5-1 planSold 2% of holdings ($693k position)14,513 shares leftFollows a Form 144Filing
- 2 Form 4 sale NUVLRoutineJul 28, 2023 +4 days
Sold 5,030 shares at $47.95 ($241k)
Turner Christopher Durant, Chief Medical Officer
10b5-1 planSold 25.7% of holdings ($937k position)14,513 shares leftFollows a Form 144Filing
- 3 Form 144 notice NUVLNoticeJul 28, 2023 same day
Filed to sell 10,660 shares ($517k)
Turner Christopher Durant, Officer
10b5-1 planFiling
- 4 Form 4 sale NUVLRoutineOct 4, 2023 +68 days
Sold 7,995 shares at $54.04 ($432k)
Turner Christopher Durant, Chief Medical Officer
10b5-1 planSold 35.5% of holdings ($1.2M position)14,513 shares left1.6x usual sizeFollows a Form 144Filing
- 5 Form 144 notice NUVLNoticeJan 6, 2025 +460 days
Filed to sell 4,250 shares ($343k)
Turner Christopher Durant, Officer
10b5-1 plan0.7x usual sizeFiling
- 6 Form 4 sale NUVLRoutineJan 6, 2025 same day
Sold 4,016 shares at $79.68 ($320k)
Turner Christopher Durant, Chief Medical Officer
10b5-1 planSold 6% of holdings ($5.3M position)62,547 shares left0.6x usual sizeFollows a Form 144Filing
- 7 Form 144 notice NUVLNoticeJan 5, 2026 +364 days
Filed to sell 7,417 shares ($724k)
Turner Christopher Durant, Officer
10b5-1 planFiling
- 8 Form 4 sale NUVLRoutineJan 6, 2026 +1 day
Sold 7,417 shares at $97.25 ($721k)
Turner Christopher Durant, Chief Medical Officer
10b5-1 planSold 11.9% of holdings ($6.1M position)55,130 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Jan 7, 2026 | NUVL | Chief Medical Officer | Form 4 sale | 7,417 | $721k | 11.9% | Routine | SEC |
| Jan 5, 2026 | Jan 5, 2026 | NUVL | Officer | Form 144 notice | 7,417 | $724k | Notice | SEC | |
| Jan 6, 2025 | Jan 8, 2025 | NUVL | Chief Medical Officer | Form 4 sale | 4,016 | $320k | 6.0% | Routine | SEC |
| Jan 6, 2025 | Jan 6, 2025 | NUVL | Officer | Form 144 notice | 4,250 | $343k | Notice | SEC | |
| Oct 4, 2023 | Oct 6, 2023 | NUVL | Chief Medical Officer | Form 4 sale | 7,995 | $432k | 35.5% | Routine | SEC |
| Jul 28, 2023 | Jul 28, 2023 | NUVL | Officer | Form 144 notice | 10,660 | $517k | Notice | SEC | |
| Jul 28, 2023 | Jul 28, 2023 | NUVL | Chief Medical Officer | Form 4 sale | 5,030 | $241k | 25.7% | Routine | SEC |
| Jul 24, 2023 | Jul 24, 2023 | NUVL | Chief Medical Officer | Form 4 sale | 300 | $14k | 2.0% | Routine | SEC |
| Jun 5, 2023 | Jun 7, 2023 | NUVL | Chief Medical Officer | Form 4 sale | 10,235 | $459k | 41.4% | Routine | SEC |
| Jun 5, 2023 | Jun 5, 2023 | NUVL | Affiliate | Form 144 notice | 12,900 | $571k | Notice | SEC |